California, United States, 29th Jan 2023 – AKARALI announces its expansion plan into the US market with a wide range clinically-tested Tongkat Ali products that are backed by two decades of research studies and clinical trials.
The herbal dietary supplement market in the US has surpassed USD10 billion for the first time in 2022.
AKARALI is on track to disrupt the billion-dollar herbal supplements industry as Americans are shifting away from generic Tongkat Ali extract from China, which are mainly sold on Amazon.
CEO of AKARALI USA, Ilan Joffee is leading this expansion plan via Core Supplements LLC, bringing with him decades of marketing experience in the North American market.
“Our presence in the US is timely as consumers are demanding higher quality Tongkat Ali extract that is clinically tested on humans. We saw a 150% month-on-month growth as AKARALI brings the best quality Tongkat Ali supplements for men. This is an important milestone for us.” Joffee said.
AKARALI contains the world’s first US-patented standardized Tongkat Ali extract that was jointly formulated by the Massachusetts Institute of Technology (MIT) with more than 26 clinical tests on humans since 2003.
Tongkat Ali first made headlines in America 25 years ago. Recent clinically tested standardized Tongkat Ali extracts are much preferred by consumers due to superior health benefits.
AKARALI Tongkat Ali products are now available on Amazon and produced in a USFDA-inspected facility that is GMP and ISO certified. This is to adhere to the best quality and safety standards.
Clinically-tested Tongkat Ali using standardized hot water extract are reviewed by many medical professionals and health experts as safe.
“We are excited to deliver higher efficacy to our US consumers from quality Tongkat Ali extract due to its faster hormonal-inducing effect on the endocrine system” Joffee said.
“Tongkat Ali (Eurycoma Longifolia) is used for centuries and is one of the few herbal supplements that is backed by more than 300 research studies in the last two decades.”, added Joffee.
Recent studies have shown positive effects in supporting healthy testosterone by up to 582%, stronger immune system, improved sexual libido and men’s fertility, improved mood and general health.
Tongkat Ali clinical trials showed promising results in addressing low testosterone symptoms, libido and stress for many years. It remains a proven dietary supplement compared to such as Panax Ginseng, Maca or Ashwagandha.
In America, Tongkat Ali has been increasingly popular amongst young adults (both men and women) and used widely as a pre and post workout supplement to increase strength and anaerobic performance.
“Thanks to increasing clinical trials and research studies, we are confident that potent and clinically tested Tongkat Ali extract is the answer that many Americans are missing at this point” he added.
Organization: akarali
Contact Person: Media Relations
Email: shahid@akarali.com
Phone: +1 (323) 369-3571
Website: http://www.akarali.com
State: California
Country: United States
Release Id: 2901232336
The post AKARALI expands in the US as consumer demands quality clinically tested Tongkat Ali products appeared first on King Newswire.
Information contained on this page is provided by an independent third-party content provider. eTrendystock make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact contact@etrendystock.com
Ripple’s highly-anticipated stablecoin RLUSD has seen a relatively muted launch, with trading volumes in the…
Bitcoin exchange-traded funds (ETFs) experienced a substantial sell-off on December 19, recording net outflows of…
Vancouver, Canada, 20th December 2024, ZEX PR WIRE, Paytora, an all-in-one digital banking platform that…
The Federal Reserve announced a 25 basis point interest rate cut, reducing the federal funds…
New York, USA, 20th December 2024, ZEX PR WIRE, Numogram ($GNON), a Solana-based project, announces…
Dubai, UAE, 20th December 2024, ZEX PR WIRE, AngelVerse is set to go live with…